• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Oseltamivir-Resistant Influenza A(H1N1)pdm09 virus associated with high case fatality, India 2015

tetano

Editor, Senior Moderator
J Med Virol. 2017 Dec 30. doi: 10.1002/jmv.25013. [Epub ahead of print]
[h=1]Oseltamivir-Resistant Influenza A(H1N1)pdm09 virus associated with high case fatality, India 2015.[/h] Tandel K[SUP]1[/SUP], Sharma S[SUP]2[/SUP], Dash PK[SUP]3[/SUP], Parida MM[SUP]4[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] Introduction Influenza A viruses has been associated with severe global pandemics of high morbidity and mortality with devastating impact on human health and global economy. India witnessed a major outbreak of influenza A(H1N1)pdm09 in 2015. This study comprises detailed investigation of cases died of influenza A(H1N1)pdm09 virus infection during explosive outbreak of 2015, in central part of India.
[h=4]OBJECTIVES:[/h] To find out presence of drug resistant virus among patients who died of influenza A(H1N1)pdm09 virus infection and to find out presence of other mutations contributing to the morbidity and mortality.
[h=4]MATERIAL & METHODS:[/h] 22 patients having confirmed influenza A(H1N1)pdm09 infection and subsequently died of this infection along with 20 non fatal cases with influenza A(H1N1)pdm09 infection were included in the study. Samples were investigated through RT-PCR/RFLP analysis, followed by nucleotide cycle sequencing of whole NA gene for detection of H275Y amino acid substitution in NA gene responsible for oseltamivir drug resistance.
[h=4]RESULTS:[/h] Out of 22 fatal cases, 6 (27.27%) were found to harbor oseltamivir resistant virus strains, whereas the H275Y mutation was not observed among the 20 non fatal cases. Amino acid substitution analysis of complete NA gene revealed V241I, N369K, N386K substitution in all strains playing synergistic role in oseltamivir drug resistance.
[h=4]CONCLUSION:[/h] High morbidity and mortality associated with influenza A(H1N1)pdm09 viruses can be explained by presence of drug resistant strains circulating in this outbreak. Presence of Oseltamivir resistant influenza A(H1N1)pdm09 viruses is a cause of great concern and warrants continuous screening for the circulation of drug resistant strains. This article is protected by copyright. All rights reserved.
This article is protected by copyright. All rights reserved.


[h=4]KEYWORDS:[/h] Antiviral Agents; Epidemiology; Evolution; Genetic variation; Genetics; Infection; Influenza virus; Mutation/Mutation rate; Pandemics; Resistance; Virus classification

PMID: 29288584 DOI: 10.1002/jmv.25013
 
Back
Top